Cancer systems biology
Applies systems biology to study cancer as a complex adaptive system.
Wikipedia / Wikimedia Commons
Cancer systems biology applies systems biology methods to cancer research, treating the disease as a complex adaptive system whose properties emerge across multiple biological scales. The goal is to analyze how the intracellular networks of normal cells become disrupted during carcinogenesis and to build predictive models that help scientists and clinicians validate new therapies and drugs. Tumors are marked by genomic and epigenetic instability, which alters the functions of many molecules and networks within a single cell and changes how that cell interacts with its local environment. Consequently, cancer systems biology relies on computational and mathematical approaches to untangle the complexity of tumorigenesis and cancer heterogeneity.
Concrete applications of this field include: developing better methods to extract insights from large-scale networks; integrating multiple data types to create more realistic models; translating knowledge about tumorigenic mechanisms into therapeutic strategies; and accounting for the tumor microenvironment at physical, cellular, and molecular levels. The field takes a holistic view, aiming to integrate many biological scales—genetics, signaling networks, epigenetics, cellular behavior, mechanical properties, histology, clinical manifestations, and epidemiology. The idea is that properties at one scale, such as histology, can be explained by properties at a lower scale, such as cell behavior. Cancer systems biology merges traditional basic and clinical cancer research with exact sciences like applied mathematics, engineering, and physics. It uses a range of omics technologies (genomics, proteomics, epigenomics, etc.) and molecular imaging to generate computational algorithms and quantitative models that reveal mechanisms underlying the cancer process and predict responses to intervention. Applications include clarifying the critical cellular and molecular networks behind cancer risk, initiation, and progression, offering an alternative to the traditional reductionist approach that focused on single molecular aberrations.
**History**
Cancer systems biology grew out of several events and realizations in biomedical research, along with technological advances. Historically, cancer was seen as a monolithic disease—a foreign, homogeneous mass best treated by excision. Besides the ongoing role of surgery, this simplistic vi
- field
- Cancer research, systems biology
- known_for
- Integrating computational and mathematical methods to decipher tumorigenesis and cancer heterogeneity
- approach
- Holistic view integrating genetics, signaling networks, epigenetics, cellular behavior, mechanical properties, histology, clinical manifestations, and epidemiology
Lore & Background
Cancer systems biology finds its roots in realizations that cancer is not a monolithic disease but a complex system. Historically, cancer was seen as a foreign, homogeneous mass best treated by excision. With molecular biology, research focused on oncogenes and tumor suppressor genes, leading to targeted therapy. However, unresolved challenges remain, including treatment failures and relapse, highlighting gaps in knowledge. Cancer systems biology aims to organize information to fill these gaps.
Reader's Guide
Cancer systems biology merges traditional basic and clinical cancer research with exact sciences like applied mathematics, engineering, and physics. It uses omics technologies and molecular imaging to generate computational algorithms and quantitative models. Applications include elucidating networks underlying cancer risk, initiation, and progression, offering an alternative to reductionist approaches. Key developments include comprehensive molecular datasets, The Cancer Genome Atlas, and mathematical modeling of cancer evolution, metabolism, and therapeutic response. The practice requires close integration of diverse scientists and training a new workforce fluent in biology and applied mathematics. At the translational level, it aims to engender precision medicine in cancer treatment.
Did You Know?
- Cancer systems biology adopts a holistic view integrating genetics, signaling networks, epigenetics, cellular behavior, mechanical properties, histology, clinical manifestations, and epidemiology.
- It incorporates a spectrum of omics technologies (genomics, proteomics, epigenomics) and molecular imaging to generate computational algorithms and quantitative models.
- Mathematical modeling has been used to identify ErbB3 as a sensitive node in the ErbB receptor signaling network, leading to clinical trials.
- The US National Cancer Institute launched a program effort on Integrative Cancer Systems Biology in 2004 to establish Centers for Cancer Systems Biology.
Frequently Asked Questions
What is Cancer systems biology?
It is a research discipline that treats cancer not as a single broken gene but as a complex adaptive system whose behavior emerges from interactions across many biological scales. Rather than studying one molecule in isolation, it maps how entire intracellular networks get rewired during carcinogenesis.
What are Cancer systems biology's powers/role?
Its core strength is weaving together computational and mathematical tools with wet-lab data to model tumorigenesis and the heterogeneity that makes each tumor unique. In practice, it builds predictive simulations that let researchers test how a proposed drug might ripple through signaling pathways before a single cell is ever treated.
How does Cancer systems biology's story end?
There is no single narrative arc; the field is ongoing, but its stated endpoint is a set of validated, patient-specific predictive models that clinicians can use to choose and sequence therapies with far greater precision. It aims to close the loop between a tumor's genomic and epigenetic instability and a concrete treatment decision at the bedside.
Why is Cancer systems biology important?
Because tumors are defined by simultaneous genomic and epigenetic instability, no single-target intervention captures the full picture of how a cell's internal networks and its local microenvironment shift together. A systems-level view is what lets scientists anticipate compensatory feedback loops and resistance mechanisms that would otherwise defeat a therapy.
What's Cancer systems biology's signature approach?
It takes a deliberately holistic stance, folding genetics, signaling networks, epigenetics, cellular mechanics, histology, clinical presentation, and even epidemiology into one integrated framework. The idea is that cancer's hallmarks only make sense when you see how properties at the molecular level propagate up to tissue and organism behavior.
More in Cancer 1-22
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record